|
ZCCHC14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.192400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.118200E-01 |
| Normal-vs-Stage2 |
1.647580E-01 |
| Normal-vs-Stage3 |
2.035900E-03 |
| Normal-vs-Stage4 |
2.39319999995047E-06 |
| Stage1-vs-Stage2 |
4.045500E-02 |
| Stage1-vs-Stage3 |
2.85270000000004E-06 |
| Stage1-vs-Stage4 |
2.6141000475377E-09 |
| Stage2-vs-Stage3 |
3.084600E-01 |
| Stage2-vs-Stage4 |
2.021900E-02 |
| Stage3-vs-Stage4 |
6.588000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.621900E-02 |
| Normal-vs-AfricanAmerican |
6.196600E-01 |
| Normal-vs-Asian |
9.073200E-01 |
| Caucasian-vs-AfricanAmerican |
5.066000E-01 |
| Caucasian-vs-Asian |
6.954800E-01 |
| AfricanAmerican-vs-Asian |
9.020800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.062300E-02 |
| Normal-vs-Female |
4.004200E-01 |
| Male-vs-Female |
2.358800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.754200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.362600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.104450E-03 |
| Normal-vs-Age(81-100Yrs) |
1.084830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.852400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.326400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.711000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.85670000000449E-05 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.252100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.586800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.762120E-03 |
| Normal-vs-Grade 2 |
6.183600E-01 |
| Normal-vs-Grade 3 |
1.754240E-02 |
| Normal-vs-Grade 4 |
1.57570000380858E-08 |
| Grade 1-vs-Grade 2 |
2.168000E-02 |
| Grade 1-vs-Grade 3 |
3.764300E-04 |
| Grade 1-vs-Grade 4 |
7.15210002333322E-09 |
| Grade 2-vs-Grade 3 |
1.081580E-03 |
| Grade 2-vs-Grade 4 |
3.5077052373822E-11 |
| Grade 3-vs-Grade 4 |
5.92529999999813E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.226190E-01 |
| Normal-vs-ccB subtype |
5.804000E-03 |
| ccA subtype-vs-ccB subtype |
1.26460000005046E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.154000E-01 |
| Normal-vs-N1 |
2.189800E-04 |
| N0-vs-N1 |
1.695900E-02 |
|
|
